These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Bispecific antibodies for cancer therapy. Hollander N Immunotherapy; 2009 Mar; 1(2):211-22. PubMed ID: 20635943 [TBL] [Abstract][Full Text] [Related]
6. Bispecific Antibody Armed T Cells to Target Cancer Cells. Thakur A; Lum LG; Mittal S Methods Mol Biol; 2018; 1722():117-126. PubMed ID: 29264802 [TBL] [Abstract][Full Text] [Related]
7. Bispecific T-cell engaging antibodies for cancer therapy. Baeuerle PA; Reinhardt C Cancer Res; 2009 Jun; 69(12):4941-4. PubMed ID: 19509221 [TBL] [Abstract][Full Text] [Related]
8. The construction of a functional photoactivatable cancer targeting bispecific antibody conjugate. Thompson S; Fawcett MC; Self CH ChemMedChem; 2007 Aug; 2(8):1162-4. PubMed ID: 17506043 [No Abstract] [Full Text] [Related]
9. Recent advances in the generation of bispecific antibodies for tumor immunotherapy. Kipriyanov SM; Le Gall F Curr Opin Drug Discov Devel; 2004 Mar; 7(2):233-42. PubMed ID: 15603258 [TBL] [Abstract][Full Text] [Related]
10. Recombinant bispecific antibodies for cellular cancer immunotherapy. Müller D; Kontermann RE Curr Opin Mol Ther; 2007 Aug; 9(4):319-26. PubMed ID: 17694444 [TBL] [Abstract][Full Text] [Related]
11. Clinical perspectives of bispecific antibodies in cancer. de Gast GC; van de Winkel JG; Bast BE Cancer Immunol Immunother; 1997; 45(3-4):121-3. PubMed ID: 9435853 [No Abstract] [Full Text] [Related]
12. Bispecific antibodies poised to deliver wave of cancer therapies. Sheridan C Nat Biotechnol; 2021 Mar; 39(3):251-254. PubMed ID: 33692520 [No Abstract] [Full Text] [Related]
13. [Bispecific Antibodies: Formats and Areas of Application]. Vasilenko EA; Mokhonov VV; Gorshkova EN; Astrakhantseva IV Mol Biol (Mosk); 2018; 52(3):380-393. PubMed ID: 29989572 [TBL] [Abstract][Full Text] [Related]
14. Antibodies and gene therapy: teaching old 'magic bullets' new tricks. Sanz L; Blanco B; Alvarez-Vallina L Trends Immunol; 2004 Feb; 25(2):85-91. PubMed ID: 15102367 [TBL] [Abstract][Full Text] [Related]
15. Alternative molecular formats and therapeutic applications for bispecific antibodies. Spiess C; Zhai Q; Carter PJ Mol Immunol; 2015 Oct; 67(2 Pt A):95-106. PubMed ID: 25637431 [TBL] [Abstract][Full Text] [Related]
16. BiTEs: bispecific antibody constructs with unique anti-tumor activity. Wolf E; Hofmeister R; Kufer P; Schlereth B; Baeuerle PA Drug Discov Today; 2005 Sep; 10(18):1237-44. PubMed ID: 16213416 [TBL] [Abstract][Full Text] [Related]
17. [Construction history of bispecific antibodies and overview of its application for cancer immunotherapy]. Asano R Seikagaku; 2005 Dec; 77(12):1497-501. PubMed ID: 16440753 [No Abstract] [Full Text] [Related]
18. Bispecific antibodies for cancer therapy. Chames P; Baty D Curr Opin Drug Discov Devel; 2009 Mar; 12(2):276-83. PubMed ID: 19333873 [TBL] [Abstract][Full Text] [Related]